Quote:
The financial press is doing MS patients no favours as they tend to sentionalize the news rather than giving it detailed research and balanced reporting.
|
I hate to say this but the financial press really doesn't give two hoots about the health or well-being of MS patients. Their only reason for reporting this information is about how it will effect Biogen's stock prices and what ramifications that means to the world of business. Detailed research and balanced reporting means nothing to them in this situation.
Harry